Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Daiichi Sankyo
QuintilesIMS
Deloitte
Cerilliant
Cantor Fitzgerald
UBS
Johnson and Johnson
Teva

Generated: February 17, 2018

DrugPatentWatch Database Preview

SODIUM PHENYLBUTYRATE Drug Profile

« Back to Dashboard

When do Sodium Phenylbutyrate patents expire, and when can generic versions of Sodium Phenylbutyrate launch?

Sodium Phenylbutyrate is a drug marketed by Par Pharm, Sigmapharm Labs Llc, and Alvogen Malta. and is included in four NDAs.

The generic ingredient in SODIUM PHENYLBUTYRATE is sodium phenylbutyrate. There are one thousand four hundred and fifteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sodium phenylbutyrate profile page.
Drug patent expirations by year for SODIUM PHENYLBUTYRATE
Pharmacology for SODIUM PHENYLBUTYRATE

US Patents and Regulatory Information for SODIUM PHENYLBUTYRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm SODIUM PHENYLBUTYRATE sodium phenylbutyrate POWDER;ORAL 203918-001 Jun 15, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm SODIUM PHENYLBUTYRATE sodium phenylbutyrate TABLET;ORAL 204395-001 Apr 15, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sigmapharm Labs Llc SODIUM PHENYLBUTYRATE sodium phenylbutyrate POWDER;ORAL 202819-001 Mar 22, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alvogen Malta SODIUM PHENYLBUTYRATE sodium phenylbutyrate TABLET;ORAL 090910-001 Nov 18, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Dow
Federal Trade Commission
US Department of Justice
Farmers Insurance
Fuji
Baxter
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot